Search Results - Kota, Poojitha

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    High prevalence of GPRC5A germline mutations in BRCA1‐mutant breast cancer patients

    High prevalence of GPRC5A germline mutations in BRCA1‐mutant breast cancer patients by Sokolenko, Anna P., Bulanova, Daria R., Iyevleva, Aglaya G., Aleksakhina, Svetlana N., Preobrazhenskaya, Elena V., Ivantsov, Alexandr O., Kuligina, Ekatherina Sh, Mitiushkina, Natalia V., Suspitsin, Evgeny N., Yanus, Grigoriy A., Zaitseva, Olga A., Yatsuk, Olga S., Togo, Alexandr V., Kota, Poojitha, Dixon, J. Michael, Larionov, Alexey A., Kuznetsov, Sergey G., Imyanitov, Evgeny N.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    High prevalence of GPRC5A germline mutations in BRCA1 -mutant breast cancer patients: GPRC5A as a modifier of BRCA1 penetrance

    High prevalence of GPRC5A germline mutations in BRCA1 -mutant breast cancer patients: GPRC5A as a modifier of BRCA1 penetrance by Sokolenko, Anna P., Bulanova, Daria R., Iyevleva, Aglaya G., Aleksakhina, Svetlana N., Preobrazhenskaya, Elena V., Ivantsov, Alexandr O., Kuligina, Ekatherina Sh, Mitiushkina, Natalia V., Suspitsin, Evgeny N., Yanus, Grigoriy A., Zaitseva, Olga A., Yatsuk, Olga S., Togo, Alexandr V., Kota, Poojitha, Dixon, J. Michael, Larionov, Alexey A., Kuznetsov, Sergey G., Imyanitov, Evgeny N.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML

    High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgro... by Heckman, Caroline A, Kontro, Mika, Pemovska, Tea, Eldfors, Samuli, Edgren, Henrik, Kulesskiy, Evgeny, Majumder, Muntasir Mamun, Karjalainen, Riikka, Yadav, Bhagwan, Szwajda, Agnieszka, Venkata, Naga Poojitha Kota, Murumägi, Astrid, Malani, Disha, Parsons, Alun, Hintsanen, Petteri, Almusa, Henrikki, Martí, Jesús María López, Ellonen, Pekka, Mattila, Pirkko, Lepistö, Maija, Lagström, Sonja, Suvela, Minna, Mustjoki, Satu, Saarela, Janna, Aittokallio, Tero, Kallioniemi, Olli, Wennerberg, Krister, Porkka, Kimmo

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 895: Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance

    Abstract 895: Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therape... by Pemovska, Tea, Kylesskiy, Evgeny, Kontro, Mika, Szwajda, Agnieszka, Karjalainen, Riikka, Majumder, Muntasir M., Malani, Disha, Bespalov, Maxim M., Eldfors, Samuli, Elonen, Erkki, Knowles, Jonathan, Murumägi, Astrid, Mpindi, John P., Edgren, Henrik, Venkata, Naga Poojitha Kota, Turunen, Laura, Mustjoki, Satu, Wolf, Maija, Yadav, Bhagwan, Aittokallio, Tero, Heckman, Caroline A., Porkka, Kimmo, Kallioniemi, Olli, Wennerberg, Krister

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 4580: Personalized treatment selection for therapy-resistant AML by integrating ex-vivo drug sensitivity and resistance testing (DSRT) as well as serial genomic, transcriptomic and phosphoproteomic profiling

    Abstract 4580: Personalized treatment selection for therapy-resistant AML by integrating ex-vivo drug sensitivity and resistance testing (DSRT) as well as serial genomic, transcrip... by Venkata, Naga Poojitha Kota, Kontro, Mika, Edgren, Henrik, Eldfors, Samuli, Pemovska, Tea, Kulesskiy, Evgeny, Majumder, Muntasir Mamun, Murumägi, Astrid, Nicorici, Daniel, Almusa, Henrikki, Mattila, Pirkko, Ellonen, Pekka, Lepistö, Maija, Mpindi, John Patrick, Karjalainen, Riikka, Parsons, Alun, Knowles, Jonathan K.C, Saarela, Janna, Wolf, Maija, Wennerberg, Krister, Heckman, Caroline A., Porkka, Kimmo, Kallioniemi, Olli

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 5067: Exome sequencing reveals both DNA sequence and copy number changes in AML: Potential driver changes and mechanisms of drug resistance revealed from serial samples from the same patients

    Abstract 5067: Exome sequencing reveals both DNA sequence and copy number changes in AML: Potential driver changes and mechanisms of drug resistance revealed from serial samples fr... by Karjalainen, Riikka, Eldfors, Samuli, Edgren, Henrik, Venkata, Naga Poojitha Kota, Kontro, Mika, Majumder, Muntasir Mamun, Murumägi, Astrid, Parsons, Alun, Almusa, Henrikki, Ellonen, Pekka, Lepistö, Maija, Mattila, Pirkko, Hannula, Sari, Lagström, Sonja, Suvela, Minna, Wolf, Maija, Wennerberg, Krister, Knowles, Jonathan KC, Mustjoki, Satu, Saarela, Janna, Porkka, Kimmo, Kallioniemi, Olli, Heckman, Caroline A.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Abstract 3188: Development of a cancer pharmacopeia-wide ex-vivo drug sensitivity and resistance testing (DSRT) platform for AML: Towards individually optimized therapy and improved understanding of drug resistance patterns

    Abstract 3188: Development of a cancer pharmacopeia-wide ex-vivo drug sensitivity and resistance testing (DSRT) platform for AML: Towards individually optimized therapy and improve... by Malani, Disha, Pemovska, Tea, Kontro, Mika, Murumägi, Astrid, Kulesskiy, Evgeny, Yadav, Bhagwan, Bespalov, Maxim, Eldfors, Samuli, Elonen, Erkki, Karjalainen, Riikka, Knowles, Jonathan KC, Majumder, Muntasir Mamun, Mpindi, John Patrick, Edgren, Henrik, Szwajda, Agnieszka, Venkata, Naga Poojitha Kota, Turunen, Laura, Mustjoki, Satu, Wolf, Maija, Aittokallio, Tero, Heckman, Caroline A., Porkka, Kimmo, Wennerberg, Krister, Kallioniemi, Olli

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients

    High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients by SOKOLENKO, Anna P, BULANOVA, Daria R, ZAITSEVA, Olga A, YATSUK, Olga S, TOGO, Alexandr V, KOTA, Poojitha, DIXON, J. Michael, LARIONOV, Alexey A, KUZNETSOV, Sergey G, IMYANITOV, Evgeny N, IYEVLEVA, Aglaya G, ALEKSAKHINA, Svetlana N, PREOBRAZHENSKAYA, Elena V, IVANTSOV, Alexandr O, KULIGINA, Ekatherina Sh, MITIUSHKINA, Natalia V, SUSPITSIN, Evgeny N, YANUS, Grigoriy A

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Abstract 65: Comprehensive ex vivo drug sensitivity testing combined with in depth molecular profiling of AML patients cells provides individualized treatment strategies and reveals mechanisms of drug resistance

    Abstract 65: Comprehensive ex vivo drug sensitivity testing combined with in depth molecular profiling of AML patients cells provides individualized treatment strategies and reveal... by Wennerberg, Krister, Pemovska, Tea, Kontro, Mika, Yadav, Bhagwan, Kulesskiy, Evgeny, Edgren, Henrik, Eldfors, Samuli, Karjalainen, Riikka, Kota Venkata, Naga Poojitha, Lehto, Anna, Majumder, Muntasir Mamun, Malani, Disha, Murumägi, Astrid, Turunen, Laura, Knowles, Jonathan, Aittokallio, Tero, Heckman, Caroline, Porkka, Kimmo, Kallioniemi, Olli

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: